NanoVibronix Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
94.00
90.00
1,614.00
106.00
4,360.00
896
Total Accounts Receivable
33.00
40.00
41.00
14.00
35.00
144
Inventories
65.00
35.00
71.00
67.00
76.00
144
Other Current Assets
32.00
-
50.00
34.00
45.00
46
Total Current Assets
224.00
165.00
1,776.00
221.00
4,516.00
1,230
Net Property, Plant & Equipment
23.00
18.00
10.00
11.00
6.00
8
Other Assets
444.00
540.00
197.00
262.00
343.00
342
Total Assets
691.00
723.00
1,983.00
494.00
4,865.00
1,580
ST Debt & Current Portion LT Debt
3,107.00
4,617.00
-
-
-
Accounts Payable
18.00
101.00
58.00
82.00
168.00
Income Tax Payable
35.00
84.00
97.00
214.00
260.00
Other Current Liabilities
398.00
618.00
142.00
269.00
369.00
Total Current Liabilities
3,558.00
5,420.00
297.00
565.00
797.00
Other Liabilities
430.00
919.00
1,895.00
2,428.00
434.00
Total Liabilities
3,988.00
6,339.00
2,192.00
2,993.00
1,231.00
Common Equity (Total)
3,297.00
5,616.00
211.00
2,501.00
3,632.00
Total Shareholders' Equity
3,297.00
5,616.00
209.00
2,499.00
3,634.00
Total Equity
3,297.00
5,616.00
209.00
2,499.00
3,634.00
Liabilities & Shareholders' Equity
691.00
723.00
1,983.00
494.00
4,865.00
Preferred Stock (Carrying Value)
-
-
2.00
2.00
2.00

About NanoVibronix

View Profile
Address
525 Executive Boulevard
New york New York 10523
United States
Employees -
Website http://www.nanovibronix.com
Updated 07/08/2019
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices that target wound healing, and pain therapy and can be administered at home, without the assistance of medical professionals. Its products include WoundShield, PainShield, and UroShield. It operates through the following geographical segments: United States, Israel, United Kingdom, European Union, India, and Other.